Acetamide, N-[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]-N-methyl-

Acetamide, N-[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]-N-methyl- Struktur
2512206-14-1
CAS-Nr.
2512206-14-1
Englisch Name:
Acetamide, N-[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]-N-methyl-
Synonyma:
(S)-N-((3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)-N-methylacetamide
CBNumber:
CB59274658
Summenformel:
C14H19NO3
Molgewicht:
249.31
MOL-Datei:
2512206-14-1.mol

Acetamide, N-[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]-N-methyl- Eigenschaften

Siedepunkt:
385.1±42.0 °C(Predicted)
Dichte
1.114±0.06 g/cm3(Predicted)
Löslichkeit
Chloroform (Slightly), Methanol (Slightly)
Aggregatzustand
Thick Oil to Waxy Solid
pka
-0.53±0.70(Predicted)
Farbe
Colourless to Pale Yellow
Stabilität:
Light Sensitive

Sicherheit

Acetamide, N-[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]-N-methyl- Chemische Eigenschaften,Einsatz,Produktion Methoden

Acetamide, N-[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]-N-methyl- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Acetamide, N-[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]-N-methyl- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 6)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Moxin Chemicals
+86-17320513646 +8617320513646
anna@molcoo.com China 10000 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 18569809817
2208093734@qq.com China 3978 58
QUALITY CONTROL SOLUTIONS LTD. +86-0755-66853366 +86-13670046396
export03@qcsrm.com China 24342 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 020-18102736 18102736234
LK@zlstandards.com China 8206 58
Changzhou Xianglong Pharmaceutical Technology Co., Ltd., 18915873328 18915873328
296197970@qq.com China 11051 58

  • (S)-N-((3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)-N-methylacetamide
  • 2512206-14-1
Copyright 2019 © ChemicalBook. All rights reserved